RehabilitationSnipperfingerNCT06924801
Integration of Real-Time Motion Tracking and Pediatric Rehabilitation
A study testing Snipperfingers in people with Rehabilitation, run by Stanford University at 1 site in United States.
Trial summary
Emerging technologies that utilize motion capture integrated with engaging software offer new methods for increasing engagement and movement in patients admitted to the hospital. Read more about this study
- Who is it for?
- Ages 6 to 17 years
- Conditions the study is for
- Rehabilitation
- What is being tested?
- Snipperfingers
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteUnited States
- Study dates
- 15 Oct 2025to Sep 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 6 to 17 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- Pediatric patients aged 6-17 years.
- Receiving physical therapy at Stanford Children's Hospital.
- Medically cleared for standing and upper-body movement.
- Ability to follow simple instructions and engage in standing gameplay
Who cannot join
- Orthopedic or medical conditions contraindicating physical activity.
- Legal guardian not present to obtain consent
- Child with a significant neurological condition or major developmental disability
- Child with active infection of the face or hand
- A history of severe motion sickness A history of seizures caused by flashing light Major surgery within the last 48 hours
Trial locations and contacts
1 site in 1 country.
United States1 site
Lucile Packard Children's Hospital Stanford
Palo Alto, California, 94304
About this study
Official title: Evaluating the Feasibility, Usability, and Integration of the OptiTrack Motion Capture System in Inpatient Physical Therapy
Emerging technologies that utilize motion capture integrated with engaging software offer new methods for increasing engagement and movement in patients admitted to the hospital. Hospitalized patients are often limited to sedentary activities, spending the majority of their time in bed, which can contribute to deconditioning and functional mobility deficits. This study seeks to explore the feasibility of a tool designed to promote movement through engaging gameplay that is acceptable to both clinicians and families.
- Conditions
- Rehabilitation
- Being tested
- Snipperfingers
- Keywords
- motion capture technology, Total translational movement
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
SnipperfingersBehavioural
Snipperfinger is a self developed engagement focused software platform designed to encourage participation in pediatric physical therapy.
| Study group | Role | What they receive |
|---|---|---|
| Pediatric patient | Experimental | Pediatric patient will engage with engagement-focused software platform (Snipperfingers) and movement will be analysed by the real-time motion capture system (the OptiTrack system). Receives: Behavioral: Snipperfingers |
What is being measured
The primary outcome is the main question the study is designed to answer.
Evaluate the ease of use of Optitrack system measured by System Usability Scale (SUS)
10-item questionnaire with a scale from 1- 5, 1 being strongly disagree to 5 being strongly agree on a five-point Likert scale to measure usability.
Measured: Post-simulation (5 minutes)]
Secondary outcomes (7)
Acceptability of Intervention Measure (AIM) survey
This questionnaire consists of 4 items. Measures are to be graded using a 1-5 scale, from 1=completely disagree, to 5= completely agree
Measured: immediately after the intervention
Intervention Appropriateness Measure (IAM) survey
This questionnaire consists of 4 items. Measures are to be graded using a 1-5 scale, from 1=completely disagree, to 5= completely agree
Measured: immediately after the intervention
Feasibility of Intervention Measure (FIM) survey
This questionnaire consists of 4 items. Measures are to be graded using a 1-5 scale, from 1=completely disagree, to 5= completely agree
Measured: immediately after the intervention
ISO 9241-400
6-item ergonomic questionnaire with a scale from 1- 5, 1 being strongly disagree to 5 being strongly agree on a five-point Likert scale.
Measured: immediately after intervention
Setup time required for system use
Time required to set up the system, defined as the duration from participant arrival in the gym to the start of the physical activity.
Measured: Before intervention
Duration of gameplay-driven physical activity
Time from first recorded movement in response to gameplay to last movement as recorded by OptiTrack motion capture or clinician observation
Measured: immediately at the start of intervention, immediately after intervention
Evaluation parent's perception of patient's engagement.
Parent acceptance of the system will be evaluated by self developed questionnaire. The questionnaire contains 10 items with scale from 1-5, 1 being strongly disagree to 5 being strongly agree on a five-point Likert scale.
Measured: immediately after intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Apr 2025
- Study start15 Oct 2025
- Primary completionSep 2027 (estimated)
- Study completionSep 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for RehabilitationStudies of the same condition, open and under way.
- More trials run by Stanford UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Stanford University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Thomas Caruso, Stanford University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06924801
- Sponsor's protocol ID
- 80334
- Acronym
- Snipperfinger
- Status last verified
- Sep 2026
- First submitted
- 4 Apr 2025
- Last updated
- 28 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 28 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluating the Feasibility, Usability, and Integration of the OptiTrack Motion Capture System in Inpatient Physical Therapy
- ClinicalTrials.gov ID
- NCT06924801
- Acronym / sponsor ID
- Snipperfinger / 80334
- Conditions
- Rehabilitation
- Keywords
- motion capture technology, Total translational movement
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- Stanford UniversityUniversity, hospital or other
- Study start
- 15 Oct 2025 (actual)
- Primary completion
- Sep 2027 (estimated)
- Study completion
- Sep 2027 (estimated)
- First posted
- 11 Apr 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Emerging technologies that utilize motion capture integrated with engaging software offer new methods for increasing engagement and movement in patients admitted to the hospital. Hospitalized patients are often limited to sedentary activities, spending the majority of their time in bed, which can contribute to deconditioning and functional mobility deficits. This study seeks to explore the feasibility of a tool designed to promote movement through engaging gameplay that is acceptable to both clinicians and families.
Study design
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Pediatric patient | Experimental | Behavioral: SnipperfingersPediatric patient will engage with engagement-focused software platform (Snipperfingers) and movement will be analysed by the real-time motion capture system (the OptiTrack system). |
Who may qualify
- Ages
- 6 to 17 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (4 listed)
- Pediatric patients aged 6-17 years.
- Receiving physical therapy at Stanford Children's Hospital.
- Medically cleared for standing and upper-body movement.
- Ability to follow simple instructions and engage in standing gameplay
Key exclusion criteria (5 listed)
- Orthopedic or medical conditions contraindicating physical activity.
- Legal guardian not present to obtain consent
- Child with a significant neurological condition or major developmental disability
- Child with active infection of the face or hand
- A history of severe motion sickness A history of seizures caused by flashing light Major surgery within the last 48 hours
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| SnipperfingersSnipperfinger is a self developed engagement focused software platform designed to encourage participation in pediatric physical therapy. | Behavioural | Pediatric patient |
Primary outcome
Evaluate the ease of use of Optitrack system measured by System Usability Scale (SUS)
Time frame: Post-simulation (5 minutes)]
10-item questionnaire with a scale from 1- 5, 1 being strongly disagree to 5 being strongly agree on a five-point Likert scale to measure usability.
7 secondary outcomes
Acceptability of Intervention Measure (AIM) survey
Time frame: immediately after the intervention
Intervention Appropriateness Measure (IAM) survey
Time frame: immediately after the intervention
Feasibility of Intervention Measure (FIM) survey
Time frame: immediately after the intervention
ISO 9241-400
Time frame: immediately after intervention
Setup time required for system use
Time frame: Before intervention
Duration of gameplay-driven physical activity
Time frame: immediately at the start of intervention, immediately after intervention
Evaluation parent's perception of patient's engagement.
Time frame: immediately after intervention
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Sep 2026.
Related trials for Rehabilitation
Not yet recruiting
Feasibility of a Robot-Guided Active Play Intervention for Children With Cerebral Palsy
Cerebral Palsy
Not yet recruiting
Effects of Hip Hinge Exercises on Pain, Range of Motion and Functional Disability in Non-specific Low Back Pain.
Low Back Pain
Recruiting
Web-Based Tele-Rehabilitation Using Action Observation and Mirror Therapy for Subacute Stroke: A Randomized Controlled Trial
Stroke, Upper Extremity Paresis
Recruiting
MyHand-SCI: An Active Hand Orthosis for Spinal Cord Injury
Spinal Cord Injuries, Tetraplegia
Recruiting
Sensory Integration Therapy vs Conventional Physical Therapy in Children With Mixed Cerebral Palsy
Cerebral Palsy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Snipperfingers in people with Rehabilitation, run by Stanford University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 28 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Evaluate the ease of use of Optitrack system measured by System Usability Scale (SUS) (time frame: Post-simulation (5 minutes)]). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Sep 2026.